Kitron ASA
13.1.2026 09:17:17 CET | Globenewswire | Press release
Kitron ASA: New share capital registered
Kitron ASA: New share capital registered
(2026-01-13) Reference is made to the stock exchange announcements made by Kitron ASA (the "Company" or "Kitron") on 19 November 2025 regarding the entering into agreement to, through its subsidiary Kitron Holding AB, acquire DeltaNordic AB (the "Transaction"), and on 12 January 2026 regarding completion of the Transaction and issuance of consideration shares.
The share capital increase pertaining to the consideration shares has now been registered in the Norwegian Register of Business Enterprises today. The Company's new registered share capital following the registration is NOK 21,870,247.10 divided into 218,702,471 shares, each with a par value of NOK 0.10. Each share gives one vote at the Company's general meeting.
Kitron is a leading Scandinavian electronics manufacturing services company for the Connectivity, Electrification, Industry, Medical devices and Defence/Aerospace sectors. The group has operations located in Norway, Sweden, Denmark, Lithuania, Germany, Poland, the Czech Republic, India, Malaysia, China and the United States. Kitron has about 3 000 employees, and revenues were EUR 647 million in 2024.
This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Trifork Group AG26.8.2026 17:43:32 CEST | Press release
51/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
Scandinavian Tobacco Group A/S26.8.2026 17:20:00 CEST | Press release
Scandinavian Tobacco Group: Interim Report 1 January – 30 June 2026: Progressing with Focus2030 and Full Year 2026 Guidance maintained
Aegon Ltd.26.8.2026 15:50:00 CEST | Press release
Aegon has filed Shareholder Circular for proposed US redomiciliation
ODDIFACT26.8.2026 15:27:59 CEST | Press release
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
Værdipapirfonden Independent Invest II26.8.2026 15:03:40 CEST | Pressemeddelelse
Fusion af afdelinger i Værdipapirfonden Independent Invest II
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom